Evolution and Risk Factors Associated With Geographic Atrophy Progression
GAIN
Characterization of Geographic Atrophy Progression in Patients With Age-related Macular Degeneration
1 other identifier
observational
96
1 country
1
Brief Summary
Age-related macular degeneration is one of the leading causes of blindness worldwide. The factors that induce the progression of geographic atrophy, the advanced form of dry age-related macular degeneration, remain poorly understood. The aims of this study are to describe the natural history of geographic atrophy and identify potential risk factors associated with a faster spread of atrophy that may be used to develop rational therapies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2009
CompletedFirst Submitted
Initial submission to the registry
September 22, 2012
CompletedFirst Posted
Study publicly available on registry
September 26, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedMarch 24, 2015
March 1, 2015
3.7 years
September 22, 2012
March 23, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Median/mean change in area of geographic atrophy as measured in mm2 with fundus autofluorescence on a 30º image centered on field 2
For measures related to change in the area of atrophy, a multivariable model will be fit and will include as an independent variable (amongst other presumed risk factors) fundus autofluorescence patterns
From baseline to last follow-up
Secondary Outcomes (1)
Median change in area of geographic atrophy as measured in square root of mm2 with fundus autofluorescence on a 30º image centered on field 2
From baseline to last follow-up
Other Outcomes (3)
Median/mean change in best-corrected visual acuity as measured with an Early Treatment Diabetic Retinopathy Study chart
From baseline to last follow-up
Percentage of eyes developing new choroidal neovascularization in the study eye as evaluated with fluorescein angiography and spectral-domain optical coherence tomography
From baseline to last follow-up
Median/mean change in area of geographic atrophy as measured in mm2 with fundus autofluorescence on a 30º image centered on field 2
From baseline to last follow-up
Study Arms (1)
Patients with geographic atrophy
Eligibility Criteria
Patients with geographic atrophy
You may qualify if:
- Both sexes
- years of age or older
- Uni or bilateral areas of geographic atrophy in the macula (as defined as areas devoid of retinal pigment epithelium measuring at least 0.5 disk areas on a 35º fundus photograph centered on field 2) secondary to age-related macular degeneration
- Willing to provide Informed consent
You may not qualify if:
- Other causes of geographic atrophy aside from age-related macular degeneration (ie, drug induced, central serous chorioretinopathy)
- Prior history of wet age-related macular degeneration
- Other significant concomitant macular diseases (ie, significant epiretinal membrane, stage II-IV macular hole)
- Previous treatment with macular laser photocoagulation, photodynamic therapy, antiangiogenic drugs or other treatments for wet age-related macular degeneration
- Intraocular surgery aside from phacoemulsification
- Inability to measure the full extent of the area of atrophy on a 35º fundus autofluorescence image centered on field 2
- Areas of geographic atrophy in direct contact with peripapillary areas of atrophy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut de la màcula i de la retina
Barcelona, Barcelona, 08017, Spain
Related Publications (4)
Biarnes M, Mones J, Trindade F, Alonso J, Arias L. Intra and interobserver agreement in the classification of fundus autofluorescence patterns in geographic atrophy secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):485-90. doi: 10.1007/s00417-011-1846-y. Epub 2011 Oct 28.
PMID: 22033626RESULTMones J, Biarnes M, Trindade F. Hyporeflective wedge-shaped band in geographic atrophy secondary to age-related macular degeneration: an underreported finding. Ophthalmology. 2012 Jul;119(7):1412-9. doi: 10.1016/j.ophtha.2012.01.026. Epub 2012 Mar 21.
PMID: 22440276RESULTMones J, Biarnes M, Trindade F, Arias L, Alonso J. Optical coherence tomography assessment of apparent foveal swelling in patients with foveal sparing secondary to geographic atrophy. Ophthalmology. 2013 Apr;120(4):829-36. doi: 10.1016/j.ophtha.2012.09.054. Epub 2013 Jan 3.
PMID: 23290986RESULTBiarnes M, Forero CG, Arias L, Alonso J, Mones J. Reappraisal of geographic atrophy patterns seen on fundus autofluorescence using a latent class analysis approach. Invest Ophthalmol Vis Sci. 2014 Nov 18;55(12):8302-8. doi: 10.1167/iovs.13-13542.
PMID: 25406275RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jordi Monés, MD, PhD
Institut de la màcula i de la retina
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
September 22, 2012
First Posted
September 26, 2012
Study Start
December 1, 2009
Primary Completion
August 1, 2013
Study Completion
August 1, 2013
Last Updated
March 24, 2015
Record last verified: 2015-03